Atrial Fibrillation study: Bachmann's Bundle Pacing
Official title Bachmann's Bundle Versus Right Atrial Appendage Pacing
ClinicalTrials.gov ID: NCT07874763
What this study is testing
- What it's testing
- The study will see if pacing from Bachmann’s Bundle or from the right atrial appendage works better for people with atrial fibrillation.
- Who it's for
- Adults who have atrial fibrillation and are eligible for a pacing procedure.
- What's involved
- Participants will receive one of the two standard pacing procedures, then have routine follow‑up visits and give blood samples and complete surveys at 3, 6, and 12 months.
- Time commitment
- The study lasts one year, with follow‑up visits at 3, 6, and 12 months and a final blood sample at one year.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients undergoing a de novo cardiac implantable electronic device (CIED) (i.e.
- Medtronic CIED system used
- Age 18 years or older
- Able to read and understand English AND EITHER 1)willing and capable of providing informed consent OR 2) in case of incompetence, be represented by a...
- Able and willing to participate in all examinations and follow-up visits and tests associated with this clinical study
You likely can't join if
- Prior CIED implant
- Known pericarditis or pericardial effusion
- New York Heart Association (NYHA) Functional Class IV
- Severe valvular disease expected to require surgical intervention within 12 months.
- History of abnormal bleeding and/or clotting disorder
- Severe lung disease, pulmonary hypertension, or any lung disease requiring home supplemental oxygen.
See the full eligibility criteria
- Patients undergoing a de novo cardiac implantable electronic device (CIED) (i.e. pacemaker, implantable cardioverter-defibrillator (ICD), CRT) implant with an atrial lead
- Medtronic CIED system used
- Age 18 years or older
- Able to read and understand English AND EITHER 1)willing and capable of providing informed consent OR 2) in case of incompetence, be represented by a legally authorized representative (LAR), relative/associate with...
- Able and willing to participate in all examinations and follow-up visits and tests associated with this clinical study
- Prior CIED implant
- Known pericarditis or pericardial effusion
- New York Heart Association (NYHA) Functional Class IV
- Severe valvular disease expected to require surgical intervention within 12 months.
- History of abnormal bleeding and/or clotting disorder
- Severe lung disease, pulmonary hypertension, or any lung disease requiring home supplemental oxygen.
- Organ or hematologic transplant, or currently being evaluated for an organ transplant
- Women who are pregnant or breastfeeding. This will be assessed clinically as per pre-procedure clinical workflow, and the research coordinator will capture the data.
The study team makes the final eligibility decision.
Where it is enrolling
- Pittsburgh, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Pittsburgh, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.